Absci Corporation ABSI
9.74
(0.61)
(5.89%)
as of 25 Sep
- Market cap
- $1.8B
- P/E
- 0.0×
Follow ABSI
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1,169.18 | 249.94 | 170.48 | 155.26 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(66.21) | (17.44) | (16.36) | (17.46) | |
P/B ratio |
7.42 | 2.67 | 2.52 | 2.08 | |
Price to Tangible BV |
8.86 | 3.50 | 3.23 | 2.60 | |
EV/Sales |
1,040.47 | 181.73 | 119.28 | 95.78 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(15.03) | (3.43) | (3.59) | (3.34) | |
EV/FCF |
(14.93) | (3.43) | (3.60) | (3.37) | |
Quick Ratio |
10.26 | 6.28 | 6.34 | 5.72 | |
Current Ratio |
10.63 | 6.59 | 6.57 | 5.89 | |
Net Debt/EBITDA |
6.39 | 4.46 | 5.08 | 6.13 | |
Debt/Assets |
0.06% | 0.21% | 0.40% | 0.56% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.01 | |
Asset Turnover |
0.01 | 0.01 | 0.01 | 0.01 | |
Operating CF/Net income |
0.83 | 0.89 | 0.99 | 0.87 | |
Capex/Depreciation |
0.02 | (0.01) | 0.08 | (0.34) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7,111.95% | 8,965.12% | 3,899.54% | 5,092.33% | |
Selling, General and Administrative Expense of Revenue |
2,881.76% | 4,213.02% | 1,325.69% | 2,233.07% | |
Intangible Assets out of Total Assets |
0.15 | 0.21 | 0.19 | 0.17 | |
Share Based Compensation of Revenue |
1,648.11% | 2,037.21% | 654.92% | 1,163.49% | |
Graham Net Nets |
0.10 | 0.24 | 0.26 | 0.32 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(6.90%) | (27.67%) | (24.36%) | (29.61%) | |
Free Cash Flow Yield |
(5.96%) | (21.20%) | (19.42%) | (18.32%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.17) | (0.17) | (0.21) | (0.17) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Free Cash Flow per Share |
(0.17) | (0.17) | (0.21) | (0.18) | |
Cash per Share |
1.28 | 0.82 | 1.05 | 1.17 | |
Shareholders Equity per Share |
1.56 | 1.12 | 1.39 | 1.46 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.56 | 1.12 | 1.39 | 1.46 | |
Free Cash Flow |
(27.52) | (26.33) | (28.95) | (25.99) | |
Working Capital |
188.67 | 111.94 | 126.81 | 145.29 | |
Capital Expenditures |
0.04 | (0.03) | 0.23 | (0.96) | |
Net Current Asset Value |
185.48 | 108.35 | 122.73 | 140.34 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.13) | 0.12 | (0.36) | 2.55 | |
Net Profit Margin |
(10,443.40%) | (13,766.98%) | (4,548.00%) | (7,594.18%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | — | — | 0.52 | |
Average Payables |
12.23 | 11.13 | 14.90 | 3.13 | |
Average Assets |
239.40 | 214.02 | 214.95 | 240.11 | |
Average Common Equity |
209.75 | 185.38 | 184.29 | 205.84 |
Columns are period end dates